{
    "id": "dbpedia_457_1",
    "rank": 55,
    "data": {
        "url": "https://dokumen.pub/handbook-of-biomaterials-biocompatibility-woodhead-publishing-series-in-biomaterials-1nbsped-0081029675-9780081029671.html",
        "read_more_link": "",
        "language": "en",
        "title": "Handbook of Biomaterials Biocompatibility (Woodhead Publishing Series in Biomaterials) [1&nbsp;ed.] 0081029675, 9780081029671",
        "top_image": "https://dokumen.pub/img/handbook-of-biomaterials-biocompatibility-woodhead-publishing-series-in-biomaterials-1nbsped-0081029675-9780081029671.jpg",
        "meta_img": "https://dokumen.pub/img/handbook-of-biomaterials-biocompatibility-woodhead-publishing-series-in-biomaterials-1nbsped-0081029675-9780081029671.jpg",
        "images": [
            "https://dokumen.pub/dokumenpub/assets/img/dokumenpub_logo.png",
            "https://dokumen.pub/img/200x200/nanoengineered-biomaterials-for-advanced-drug-delivery-woodhead-publishing-series-in-biomaterials-1nbsped-0081029853-9780081029855.jpg",
            "https://dokumen.pub/img/200x200/biointegration-of-medical-implant-materials-woodhead-publishing-series-in-biomaterials-2nbsped-0081026803-9780081026809.jpg",
            "https://dokumen.pub/img/200x200/engineering-drug-delivery-systems-woodhead-publishing-series-in-biomaterials-1nbsped-0081025483-9780081025482.jpg",
            "https://dokumen.pub/img/200x200/artificial-protein-and-peptide-nanofibers-design-fabrication-characterization-and-applications-woodhead-publishing-series-in-biomaterials-1nbsped-0081028504-9780081028506.jpg",
            "https://dokumen.pub/img/200x200/biomaterials-in-asia-in-commemoration-of-the-1st-asian-biomaterials-congress-9789812835758-9789812835741.jpg",
            "https://dokumen.pub/img/200x200/dental-implants-materials-coatings-surface-modifications-and-interfaces-with-oral-tissues-woodhead-publishing-series-in-biomaterials-1nbsped-012819586x-9780128195864.jpg",
            "https://dokumen.pub/img/200x200/shoulder-and-elbow-trauma-and-its-complications-volume-2-the-elbow-woodhead-publishing-series-in-biomaterials-1nbsped-1782424504-9781782424505.jpg",
            "https://dokumen.pub/img/200x200/characterization-of-biomaterials-9780124158634-9780124158009.jpg",
            "https://dokumen.pub/img/200x200/biomaterials-9780841225671-9780841225688.jpg",
            "https://dokumen.pub/img/200x200/comprehensive-biomaterials-2011933642-9780080553023.jpg",
            "https://dokumen.pub/img/200x200/handbook-of-biomaterials-biocompatibility-woodhead-publishing-series-in-biomaterials-1nbsped-0081029675-9780081029671.jpg",
            "https://dokumen.pub/dokumenpub/assets/img/dokumenpub_logo.png"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [],
        "publish_date": null,
        "summary": "",
        "meta_description": "Handbook of Biomaterials Biocompatibility is a systematic reference on host response to different biomaterials, taking i...",
        "meta_lang": "en",
        "meta_favicon": "https://dokumen.pub/dokumenpub/assets/img/apple-icon-57x57.png",
        "meta_site_name": "dokumen.pub",
        "canonical_link": "https://dokumen.pub/handbook-of-biomaterials-biocompatibility-woodhead-publishing-series-in-biomaterials-1nbsped-0081029675-9780081029671.html",
        "text": "Table of contents :\n\nCover\n\nHANDBOOK OF\n\nBIOMATERIALS\n\nBIOCOMPATIBILITY\n\nCopyright\n\nContents\n\nList of Contributors\n\nPreface\n\nAcknowledgments\n\nSec1\n\n1 Principles of biocompatibility\n\n1.1 Introduction\n\n1.2 Conclusion\n\nReferences\n\nFurther reading\n\n2 Bacterial cell–biomaterials interactions\n\n2.1 Introduction\n\n2.2 Theoretical theories of bacterial adhesion to biomaterial surfaces\n\n2.3 Factors influencing bacterial adhesion to biomaterial surfaces\n\n2.3.1 Biomaterial surface properties\n\n2.3.2 Plasma proteins\n\n2.3.3 Platelets\n\n2.3.4 Fluid flow\n\n2.4 Bacterial interaction with antibacterial biomaterial surfaces\n\n2.5 Signaling molecules in the regulation of bacterial adhesion on biomaterial surfaces\n\n2.6 Summary and perspectives\n\nReferences\n\n3 Macrophage response to biomaterials\n\n3.1 The macrophage\n\n3.2 Macrophage plasticity and polarization\n\n3.3 The macrophage response to biomaterials\n\n3.4 The macrophages and the development of immunomodulatory biomaterials\n\n3.4.1 Immunomodulatory biomaterials\n\n3.4.2 Macrophages in immunomodulation\n\nReferences\n\n4 Dendritic cells responses to biomaterials\n\n4.1 Introduction\n\n4.2 Natural polymer biomaterials\n\n4.3 Gelatin\n\n4.4 Alginate\n\n4.5 Chitosan\n\n4.6 Synthetic polymer biomaterials\n\n4.7 Poly(lactic-co-glycolic acid)\n\n4.8 Polyethylene glycol\n\n4.9 Blends\n\n4.10 Poly(lactic-co-glycolic acid)-chitosan\n\n4.10.1 Monomethoxy poly(ethylene glycol)-poly(lactic-co-glycolic acid)\n\n4.11 Conclusion and future directions\n\nReferences\n\n5 Impact of biomaterials’ physical properties on cellular and molecular responses\n\nAbbreviations\n\n5.1 Introduction\n\n5.2 Cellular and molecular response following implantation\n\n5.2.1 Blood-materials interaction\n\n5.2.2 Acute inflammation\n\n5.2.3 Chronic inflammation\n\n5.2.4 Wound healing\n\n5.2.5 Foreign body reaction\n\n5.2.6 Fibrous capsule formation\n\n5.3 Impact of physical properties on modulation of the host response\n\n5.3.1 Size\n\n5.3.2 Configuration and topography\n\n5.3.3 Stiffness\n\n5.3.4 Surface chemistry\n\n5.4 Conclusion\n\nReferences\n\n6 Impact of biomaterial mechanics on cellular and molecular responses\n\n6.1 Introduction\n\n6.2 Host response—biomaterial interplay\n\n6.2.1 Phase I\n\n6.2.2 Phase II\n\n6.2.3 Phase III\n\n6.2.4 Phase IV\n\n6.2.5 Phase V\n\n6.3 Other significant players of the foreign body reaction\n\n6.4 Impact of biomaterial surface characteristics on the sequential phases of host response\n\n6.4.1 On protein adsorption\n\n6.4.2 On acute inflammation\n\n6.4.3 On chronic inflammation\n\n6.4.4 On foreign body giant cell formation\n\n6.4.5 On capsule formation and fibrosis\n\n6.5 Conclusion\n\nConflict of interest\n\nReferences\n\n7 Cell–biomaterials interactions: the role of growth factors\n\n7.1 Introduction\n\n7.2 What are growth factors?\n\n7.3 Growth factors in bone tissue engineering\n\n7.4 Bone morphogenetic proteins\n\n7.5 Transforming growth factor βs\n\n7.6 Platelet-derived growth factors\n\n7.7 Fibroblast growth factors\n\n7.8 Insulin-like growth factors\n\n7.9 Bone growth factors clinical applications\n\n7.10 Conclusion and perspectives\n\nConflict of interest\n\nReferences\n\n8 Cell–biomaterial interactions: the role of ligand functionalization\n\n8.1 Introduction\n\n8.2 Ligand functionalization in the design of bioactive hydrogels\n\n8.2.1 General functionalization strategies for hydrogels\n\n8.2.2 Peptide functionalization of hydrogels for cardiac tissue engineering\n\n8.3 Ligand surface functionalization in the design of scaffolds and implants\n\n8.4 Ligand functionalization of nanoparticles for cell targeting\n\n8.5 General discussion and conclusion\n\nReferences\n\n9 On the proliferation of cell proliferation tests\n\n9.1 Introduction\n\n9.1.1 The need and challenge of assessing cell proliferation on biomaterials\n\n9.1.2 Cell proliferation versus cell viability\n\n9.2 Methods to measure cell proliferation\n\n9.2.1 Metabolism-based assays\n\n9.2.1.1 MTT\n\n9.2.1.2 Other tetrazolium salts\n\nWST-1\n\nXTT\n\nMTS\n\nCCK8\n\n9.2.2 alamarBlue\n\n9.2.3 Nucleic acid-based assays\n\n9.2.3.1 PicoGreen and CyQUANT\n\n9.2.3.2 Thymidine analogues\n\n9.2.4 Other methods\n\n9.2.4.1 Adenosine triphosphate\n\n9.2.4.2 Immunofluoresence markers\n\n9.2.4.3 Nuclei counting\n\n9.2.4.4 Hemacytometer\n\n9.2.4.5 Transepithelial/transendothelial electrical resistance\n\n9.2.4.6 Flow cytometry\n\n9.3 Comparison of proliferation tests\n\n9.4 Special challenges and experimental design considerations\n\n9.4.1 Cell seeding and proliferation in three-dimensional scaffolds\n\n9.4.2 Cell density\n\n9.4.3 Bioactive materials\n\n9.4.4 Controls\n\n9.5 Conclusion\n\nReferences\n\n10 In vivo models for biomaterials: applications from cardiovascular tissue engineering\n\nAbbreviations\n\n10.1 Introduction\n\n10.2 Constructs and biomaterials used in cardiac tissue engineering\n\n10.2.1 Materials for cell delivery to cardiac tissue\n\n10.2.2 Cardiac tissue patches\n\n10.2.2.1 Decellularized materials\n\n10.2.2.2 Electrically conductive materials\n\n10.2.3 Construct performance in vivo\n\n10.2.3.1 Material degradation\n\n10.2.3.2 Immunogenicity: macrophage infiltration\n\n10.2.3.3 Neovasculature and angiogenesis\n\n10.2.4 Scarring and arrhythmogenesis\n\n10.2.4.1 Assessment of arrhythmogenicity\n\n10.2.4.2 Arrhythmogenicity of biomaterials\n\n10.2.4.3 Mitigating the risk of arrhythmogenesis\n\n10.2.5 Challenges of biomaterials used in cardiac tissue engineering\n\n10.3 Constructs and biomaterials used in vascular tissue engineering\n\n10.3.1 Biomaterials used in vascular tissue engineering\n\n10.3.2 Fabrication methods\n\n10.3.3 Construct performance in vivo\n\n10.3.3.1 Blood clots\n\n10.3.3.2 Vessel integrity and aneurysm formation\n\n10.3.3.3 Immunogenicity\n\n10.4 In vivo applications of constructs and biomaterials\n\n10.5 Conclusion\n\nReferences\n\n11 Clinical and surgical aspects of medical materials’ biocompatibility\n\nAuthor disclosure statement\n\nAbbreviations\n\n11.1 Introduction\n\n11.2 Orthopedic biomaterials\n\n11.2.1 Fracture fixation applications\n\n11.2.2 Joint replacement applications\n\n11.2.3 Graft applications (auto-, allo-, xeno-)\n\n11.2.4 Synthetic grafts and filling material applications\n\n11.3 General and reconstructive surgery biomaterials\n\n11.3.1 Injectable biomaterials\n\n11.3.2 Reconstructive breast surgery and breast implants\n\n11.3.3 Hernia repair and mesh materials\n\n11.4 Cardiovascular biomaterials\n\n11.4.1 Coronary stents\n\n11.4.2 Heart valves\n\n11.4.3 Implantable pacemakers\n\n11.4.4 Left ventricular assist devices\n\n11.4.5 Vascular grafts\n\n11.5 Conclusion\n\nReferences\n\n12 Standardization and regulation of biomaterials\n\n12.1 Introduction\n\n12.2 Biomaterials for therapeutic and regenerative medicine\n\n12.2.1 Biomaterial design, fabrication, characterization, and documentation\n\n12.2.2 In vitro cellular response analysis for biomaterials study\n\n12.2.3 In vivo animal model for biomaterials study\n\n12.3 Discussion\n\n12.3.1 Standardization of experimental protocols\n\n12.3.2 Biomaterial regulations and policies\n\n12.3.3 Translation and society\n\n12.3.4 Medico-legal and health insurance systems\n\n12.4 Conclusion\n\nReferences\n\nSec2\n\n13 Cellular response to synthetic polymers\n\nAbbreviations\n\n13.1 Introduction\n\n13.2 Cellular response to synthetic nondegradable polymers\n\n13.2.1 Poly(ethylene), poly(methyl methacrylate), and poly(tetrafluoroethylene) in bone regeneration\n\n13.2.1.1 Inflammatory changes preceding osteolysis\n\n13.2.1.2 Osteolysis\n\n13.2.2 Poly(propylene), poly(tetrafluoroethylene), and poly(ethylene terephthalate) as surgical meshes\n\n13.2.2.1 Biologic response to mesh\n\n13.2.3 Cellular response to synthetic polymers used in cardiac surgery\n\n13.2.3.1 Poly(vinyl chloride), poly(tetrafluoroethylene), poly(urethane), and poly(ethylene) as catheters in cardiac surgery\n\n13.2.3.2 Poly(ethylene terephthalate) and poly(tetrafluoroethylene) used in cardiac surgery\n\n13.2.4 Cellular response to poly(methyl methacrylate)\n\n13.2.5 Cellular response to poly(urethane) and poly(amides) (nylon)\n\n13.2.6 Cellular response to poly(styrene)\n\n13.2.6.1 Poly(styrene) as a cell culture material\n\n13.2.6.2 Surface functionalization by liquid treatment\n\n13.2.6.3 Surface functionalization by plasma treatment\n\n13.2.6.4 Surface functionalization by other methods\n\n13.2.7 Cellular response to other synthetic polymers\n\n13.2.7.1 Poly(sulfone)\n\n13.2.7.2 Polyethersulfone\n\n13.2.7.3 Poly(etherimide)\n\n13.2.7.4 Poly(etheretherketone)\n\n13.3 Cellular response to biodegradable/resorbable polymers\n\n13.3.1 Cellular response to poly(lactic acid)\n\n13.3.2 Cellular response to polycarbonates\n\n13.4 Conclusion and future trends\n\nReferences\n\n14 Cellular responses to zirconia\n\n14.1 Introduction\n\n14.2 “Aging” of zirconia\n\n14.3 Definitions of biocompatibility, osseointegration, osteoinductivity, and osteoconductivity\n\n14.4 In vitro zirconia biocompatibility\n\n14.4.1 Cellular response of the fibroblasts\n\n14.4.2 Cellular response of leukocyte cell lines\n\n14.4.3 Cellular response of osteoblasts and osteoclast\n\n14.5 In vivo zirconia biocompatibility\n\n14.6 Conclusion\n\nReferences\n\n15 Cellular response to alumina\n\n15.1 Introduction\n\n15.2 Physicochemical properties of alumina surface\n\n15.3 Cellular responses and protein adsorption on alumina surface\n\n15.4 Futures and conclusion\n\nReferences\n\n16 Biocompatibility of graphene quantum dots and related materials\n\nAbbreviations\n\n16.1 Introduction\n\n16.2 In vitro biocompatibility studies\n\n16.2.1 In vitro biocompatibility study of graphene quantum dot\n\n16.2.2 In vitro biocompatibility study of graphene derivatives\n\n16.3 In vivo biocompatibility studies\n\n16.3.1 In vivo biocompatibility study of graphene quantum dots\n\n16.3.2 In vivo biocompatibility study of graphene derivatives\n\n16.4 Biocompatibility study of other carbon nanostructures\n\n16.4.1 Biocompatibility study of carbon nanotube\n\n16.4.2 Biocompatibility study of fullerene\n\n16.4.3 Biocompatibility study of carbon dot\n\n16.4.4 Biocompatibility study of nanodiamond\n\n16.5 Approaches to reduce toxicity\n\n16.5.1 Green synthesis\n\n16.5.2 Coating/functionalization\n\n16.6 Conclusion\n\nReferences\n\n17 Cellular response to calcium phosphate cements\n\n17.1 Introduction\n\n17.2 General characteristics of calcium phosphate cement\n\n17.3 Chemistry and handling\n\n17.4 Biological evaluation of calcium phosphate cements\n\n17.5 Biodegradation of calcium phosphate cements\n\n17.6 Bioactivity of calcium phosphate cements\n\n17.7 Osteoconductivity of calcium phosphate cements\n\n17.8 Osteoinductivity of calcium phosphate cements\n\n17.9 Cellular response to calcium phosphate cements\n\n17.10 Clinical applications\n\nReferences\n\n18 Cellular response to bioactive glasses and glass–ceramics\n\n18.1 Introduction\n\n18.2 Biological responses to biomaterials\n\n18.3 Bioactive glasses and glass–ceramics: structure and their physicochemical properties\n\n18.3.1 Silicate-based glasses\n\n18.3.2 Borate-based glasses\n\n18.3.3 Phosphate-based glasses\n\n18.4 Innovative strategies for selective contribution of bioactive glasses\n\n18.4.1 Cellular and molecular behavior of bioactive glasses in response to different doped ions\n\n18.4.1.1 Fluoride-containing bioactive glasses\n\n18.4.1.2 Magnesium containing bioactive glasses\n\n18.4.1.3 Strontium containing bioactive glasses\n\n18.4.1.4 Silver-containing bioactive glasses\n\n18.4.1.5 Copper-containing bioactive glasses\n\n18.4.1.6 Zinc-containing bioactive glasses\n\n18.4.1.7 Cobalt-containing bioactive glasses\n\n18.4.2 Silanization\n\n18.4.3 Surface functionalization of bioactive glasses through biological approaches\n\n18.5 Commercialized bioactive glasses and glass–ceramics\n\n18.6 Discussion\n\n18.7 Conclusion\n\nReferences\n\n19 Cell responses to titanium and titanium alloys\n\n19.1 Introduction\n\n19.2 Surface modification of titanium alloys to induce appropriate cell responses\n\n19.2.1 Repair and regeneration of hard tissues\n\n19.2.1.1 Surface topography and surface roughness\n\n19.2.1.2 Surface wettability and free energy\n\n19.2.1.3 Surface chemistry\n\nInorganic coatings\n\nOrganic coatings\n\n19.2.2 Repair and attachment of soft tissue\n\n19.2.3 Modulation of the immune response\n\n19.3 Antimicrobial coatings on titanium\n\n19.3.1 Coatings\n\n19.3.1.1 Antibiotic coatings\n\n19.3.1.2 Antimicrobial peptide coatings\n\n19.3.1.3 Other organic antimicrobial coatings\n\n19.3.1.4 Inorganic antimicrobial coatings\n\n19.3.2 Surface nanostructures to prevent bacteria colonization\n\n19.4 Conclusion\n\nReferences\n\n20 Cellular response to metal implants\n\n20.1 Introduction\n\n20.2 Metallic implants\n\n20.2.1 Orthopedic devices\n\n20.2.2 Cardiac and endovascular implants\n\n20.2.3 Dental and oral/maxillofacial devices\n\n20.2.4 Neurological devices\n\n20.2.5 Gynecological devices\n\n20.3 Corrosion and metal ion release\n\n20.4 Cellular response to metal implants\n\n20.4.1 Inflammatory response\n\n20.4.1.1 Coagulation, complement activation, and protein adsorption\n\n20.4.1.2 Danger signals and recognition\n\n20.4.1.3 Activation of inflammatory cells\n\n20.4.2 Chronic inflammation\n\n20.4.3 Adaptive immune response\n\n20.4.3.1 Sensitization\n\n20.4.3.2 Effects of metals in adaptive immunity\n\n20.5 Modulation of host response to implants\n\n20.6 Conclusion\n\nReferences\n\n21 Cellular response to nanobiomaterials\n\n21.1 Introduction\n\n21.2 Factors affecting nanobiomaterial–cell interactions\n\n21.2.1 Chemistry of nanobiomaterials\n\n21.2.2 Size of nanobiomaterials\n\n21.2.3 Shape of nanobiomaterials\n\n21.2.4 Surface topography and stiffness of nanobiomaterials\n\n21.2.5 Surface charge\n\n21.2.6 Functional groups of nanobiomaterials\n\n21.2.7 Hydrophobicity/hydrophilicity of nanobiomaterials\n\n21.3 Various interactions between nanobiomaterials and cells\n\n21.3.1 Nanobiomaterial–ECM interactions\n\n21.3.2 Nanobiomaterial–cell membrane interaction\n\n21.3.3 Nanobiomaterial–cytoskeleton interactions\n\n21.3.4 Nanobiomaterial–organelle interactions\n\n21.3.5 Nanobiomaterial–nuclei interactions\n\n21.4 Conclusion\n\nReferences\n\nSec 3\n\n22 Central nervous system responses to biomaterials\n\n22.1 Introduction\n\n22.1.1 The need for the use of biomaterials in central nervous system\n\n22.1.2 Classification of biomaterials used in central nervous system\n\n22.2 Polymers\n\n22.2.1 Synthetic polymers\n\n22.2.1.1 Poly(glycolic acid)/poly(lactic acid)/poly(lactic-co-glycolic acid)\n\n22.2.1.2 Poly(ε-caprolactone)\n\n22.2.1.3 Poly(ethylene glycol)/poly(ethylene oxide)\n\n22.2.1.4 Poly(ethylene-co-vinylacetate)\n\n22.2.1.5 Poly(2-hydroxyethyl methacrylate) and poly(2-hydroxyethyl methacrylate-co-methyl methacrylate)\n\n22.2.2 Natural polymers\n\n22.2.2.1 Agarose/alginate\n\n22.2.2.2 Chitosan/methylcellulose/nitrocellulose\n\n22.2.2.3 Collagen\n\n22.2.2.4 Dextran\n\n22.2.2.5 Fibrin/fibronectin\n\n22.2.2.6 Hyaluronan/hyaluronic acid\n\n22.2.3 Conductive polymers\n\n22.2.3.1 Polypyrrole\n\n22.2.3.2 Polyaniline\n\n22.2.3.3 Poly(3,4-ethylenedioxythiopene)\n\n22.2.3.4 Indium phosphide\n\n22.2.3.5 Carbon nanomaterials (i.e., graphene, carbon nanotubes)\n\n22.3 Metals\n\n22.3.1 Introduction and unspecific toxicities\n\n22.3.2 Iron (Fe)\n\n22.3.3 Chromium (Cr)\n\n22.3.4 Cobalt (Co)\n\n22.3.5 Molybdenum (Mo)\n\n22.3.6 Nickel (Ni)\n\n22.3.7 Titanium (Ti)\n\n22.3.8 Tungsten (W) and iridium (Ir)\n\n22.3.9 Platinum (Pt)\n\n22.3.10 Management of metal induced toxicities\n\n22.4 Ceramics\n\n22.4.1 Silicon oxides\n\n22.4.2 Aluminum oxides\n\n22.4.3 Titanium oxides\n\n22.5 Hybrid or composite biomaterials\n\n22.5.1 Interaction of nanomaterials and nanoparticles with central nervous system\n\n22.5.2 Carbon nanomaterials\n\n22.5.2.1 Carbon nanotubes\n\n22.5.2.2 Fullerenes\n\n22.5.2.3 Graphene oxide and derived nanomaterials\n\n22.5.2.4 Nanodiamonds\n\n22.5.2.5 Carbon nanohorns and carbon nanofibers\n\n22.5.2.6 Carbon dots\n\n22.6 Conclusion and future directions\n\nConflicts of interest\n\nReferences\n\n23 Peripheral nervous system responses to biomaterials\n\n23.1 Introduction\n\n23.1.1 Non synthetic nerve guidance conduits\n\n23.1.1.1 Autografts\n\n23.1.1.2 Blood vessels\n\n23.1.1.3 Muscle\n\n23.2 Allografts\n\n23.3 Xenografts\n\n23.4 Natural degradable nerve guidance conduits\n\n23.4.1 Collagen\n\n23.4.2 Gelatin\n\n23.4.3 Fibrin\n\n23.4.4 Keratin\n\n23.4.5 Silk\n\n23.4.6 Chitosan\n\n23.5 Synthetic nerve guidance conduits\n\n23.6 Synthetic degradable nerve guidance conduits\n\n23.7 Polymers\n\n23.7.1 Poly (e-caprolactone) (PCL)\n\n23.7.2 Polyurethanes\n\n23.7.3 Polyglycolic acid\n\n23.8 Summary\n\nReferences\n\n24 Cardiac responses to biomaterials\n\n24.1 Biomaterials for cardiac applications\n\n24.2 Foreign body response\n\n24.3 Biocompatibility testing of biomaterials\n\n24.3.1 Identification and quantification of the foreign body response—histology\n\n24.3.2 Identification and quantification of the foreign body response—proteomics\n\n24.4 Biomaterials\n\n24.4.1 Mechanical support\n\n24.4.1.1 Alginate\n\n24.4.1.2 Decellularized tissue\n\n24.4.1.3 Hyaluronic acid\n\n24.4.1.4 Synthetic biomaterials\n\n24.4.2 Cell delivery\n\n24.4.2.1 Fibrin\n\n24.4.2.2 Poly(ethylene glycol)\n\n24.4.2.3 Cardiac patches—poly(ester urethane)\n\n24.4.2.4 Cardiac patches—polycaprolactone\n\n24.4.2.5 Cardiac patches—collagen\n\n24.4.2.6 Cardiac patches—poly(urethane)\n\n24.4.3 Growth factor/small molecule delivery\n\n24.4.3.1 Chitosan\n\n24.4.3.2 Poly(lactide-co-glycolic acid)\n\n24.4.3.3 N-isopropylacrylamide\n\n24.4.4 Prosthetic valves\n\n24.4.5 Traditional medical devices\n\n24.4.5.1 Pacemakers and Implantable Cardioverter Defibrillators (ICDs)\n\n24.4.5.2 Stents\n\n24.5 State of the art approaches to reduce the foreign body response\n\n24.5.1 Material properties\n\n24.5.2 Device design\n\n24.5.3 Coatings\n\n24.5.4 Use of angiogenic agents\n\n24.5.5 Inhibition of TGF-β/use of corticosteroids\n\n24.5.6 Mechanical actuation\n\n24.5.7 Monitoring the foreign body response\n\n24.6 Potential uses of the foreign body response\n\n24.7 Conclusion\n\nReferences\n\n25 Vascular responses to biomaterials\n\n25.1 Introduction\n\n25.2 Biomaterials in vascular diseases\n\n25.2.1 Biocompatibility\n\n25.2.2 Metals and alloys\n\n25.2.3 Polymer-based implants\n\n25.2.4 Biological materials\n\n25.3 Vascular response to biomaterials\n\n25.3.1 Biomaterials and clotting\n\n25.3.2 Biomaterials and acute inflammation\n\n25.3.3 Restenosis\n\n25.3.4 Fibrosis\n\n25.4 Vascular response to biofunctionalization of biomaterials\n\n25.4.1 Antiproliferative strategies\n\n25.4.2 Antithrombogenic strategies\n\n25.4.3 Reendothelialization strategies\n\n25.4.4 Antiinflammatory and antifibrotic strategies\n\n25.5 Future perspectives\n\nReferences\n\n26 Bone responses to biomaterials\n\nAbbreviations\n\n26.1 Introduction\n\n26.2 Skeletal cell response to biomaterials\n\n26.2.1 Osteoblasts\n\n26.2.2 Osteoclasts\n\n26.2.3 Osteocytes\n\n26.3 Immune cell response to biomaterials\n\n26.3.1 Macrophages\n\n26.3.2 Neutrophils and dendritic cells\n\n26.3.3 T cells\n\n26.4 Vascular cell response to biomaterials\n\n26.5 Conclusion\n\nReferences\n\n27 Tendon and muscle responses to biomaterials\n\n27.1 Introduction\n\n27.1.1 Composition of tendon and muscle tissues\n\n27.1.2 Injury and healing of tendon/muscle\n\n27.2 Management of tendon/muscle injuries and responses\n\n27.2.1 Suture\n\n27.2.2 Tissue grafting\n\n27.3 Regenerative strategies for tendon/muscle injuries\n\n27.3.1 Hydrogel biomaterials for small tissue repair\n\n27.3.2 Natural biomaterials for large tissue repairs\n\n27.3.2.1 Collagen\n\n27.3.2.2 Silk\n\n27.3.3 Synthetic materials for large tissue repairs\n\n27.4 Conclusion\n\nReferences\n\n28 Pulmonary system responses to biomaterials\n\n28.1 Introduction\n\n28.2 Synthetic biomaterials and their applications in pulmonary administration\n\n28.2.1 Poly(ethylene terephthalate)\n\n28.2.2 Poly(tetrafluoroethylene)\n\n28.2.3 Poly(glycolic acid)\n\n28.2.4 Polyvinyl alcohol\n\n28.2.5 Polyethylene glycol\n\n28.3 Synthetic biomaterials for drug delivery in lungs\n\n28.4 Uses of synthetic biomaterials in lung tissue engineering\n\n28.5 Natural biomaterials for pulmonary applications\n\n28.5.1 Albumin-based biomaterials\n\n28.5.2 Derivatives from silk\n\n28.5.3 Chitosan and its derivatives\n\n28.5.4 Gelatin\n\n28.5.5 Hyaluronic acid\n\n28.6 Conclusion\n\nReferences\n\n29 Gastrointestinal response to biomaterials\n\n29.1 Introduction\n\n29.2 Oral cavity and pharynx\n\n29.3 Oesophagus\n\n29.4 Stomach\n\n29.5 Small intestine\n\n29.6 Large intestine\n\n29.7 Conclusion\n\nReferences\n\n30 Ocular responses to biomaterials\n\n30.1 Introduction to biocompatibility in the eye\n\n30.2 Anatomy and physiology of the eye in relation to biomaterial applications\n\n30.2.1 The ocular surface\n\n30.2.2 The anterior segment of the eye\n\n30.2.3 The posterior segment\n\n30.3 Ocular response to biomaterials in the anterior chamber\n\n30.3.1 Ocular response to contact lens and artificial cornea materials\n\n30.3.2 Ocular response to intraocular lens\n\n30.3.3 Ocular response to glaucoma shunts and (noncontact lens) drug delivery systems in the anterior eye\n\n30.4 Ocular response to biomaterials in the posterior segment\n\n30.5 Conclusion\n\nReferences\n\n31 Skin responses to biomaterials\n\n31.1 Introduction\n\n31.2 General description of the skin tissue\n\n31.3 Skin responses to biomaterials\n\n31.3.1 The inflammatory response induced by biomaterials on skin\n\n31.3.2 The hypersensitivity responses induced by biomaterials on skin\n\n31.3.3 The stimuli responses induced by biomaterials on skin\n\n31.3.3.1 Biomaterial physical properties\n\n31.3.3.2 Bioactive strategies\n\n31.3.3.3 Biomaterial mechanical properties and stimulus signal\n\n31.3.3.4 Metal ions and inorganic compounds\n\n31.4 The role of scaffolding materials in skin tissue engineering\n\n31.5 Future perspectives\n\nReferences\n\nIndex\n\nBack Cover\n\nCitation preview"
    }
}